Advertisement

Topics

EndoClot Plus, Inc. Company Profile

21:46 EST 13th December 2018 | BioPortfolio

EndoClot Plus, Inc. (EPI) is a privately owned company in Santa Clara, California. In collaboration with surgeons and biomaterial scientists, EPI developed a breakthrough technology to control bleeding in the gastrointestinal tract by spraying a unique and proprietary powder directly to the wound during endoscopy. The EndoClot® Polysaccharide Hemostatic System (EndoClot® PHS) is currently being sold outside the U.S. in selected international markets. The mission of EndoClot Plus is to provide new therapeutic solutions to the world market for GI Endoscopy.


News Articles [0 Results]

None

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [3 Associated Clinical Trials listed on BioPortfolio]

Italian Multicenter Prospective Randomized Trial to Compare Additive Hemostatic Efficacy of EndoClot System to Prevent Bleeding After Endoscopic Mucosal Resection or Endoscopic Submucosal Dissection of Lesions in the Gastrointestinal Tract

We want to verify in a randomised trial, the effectiveness of EndoClotTM in preventing post-procedural bleeding after EMR (Endoscopic Mucosal Resection) or ESD (Endoscopic Submucosal Disse...

Efficacy of Hemostatic Powder, Endo-ClotTM in the Endoscopic Treatment of Acute Upper Gastrointestinal Bleeding

Acute upper gastrointestinal hemorrhage (UGIH) is a common condition that leads to hospital admission, and has significant associated morbidity and mortality, especially in the elderly. Th...

Efficacy of Hemostatic Powder in Preventing Bleeding After Gastric Endoscopic Submucosal Dissection in High-risk Patients: A Prospective Randomized Control Study

Endoscopic submucosal dissection (ESD) for superficial gastric neoplasm is minimally invasive and achieves curative resection with an acceptable rate of adverse events. Although the safety...

Companies [1 Associated Companies listed on BioPortfolio]

EndoClot Plus, Inc.

EndoClot Plus, Inc. (EPI) is a privately owned company in Santa Clara, California. In collaboration with surgeons and biomaterial scientists, EPI developed a breakthrough technolo...

More Information about "EndoClot Plus, Inc." on BioPortfolio

We have published hundreds of EndoClot Plus, Inc. news stories on BioPortfolio along with dozens of EndoClot Plus, Inc. Clinical Trials and PubMed Articles about EndoClot Plus, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of EndoClot Plus, Inc. Companies in our database. You can also find out about relevant EndoClot Plus, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Biomaterial
A biomaterial is defined as a substance that has been engineered to take a form which, alone or as part of a complex system, is used to direct, by control of interactions with components of living systems, the course of any therapeutic or diagnostic proc...

Wound management
Anything that breaks the skin is a wound because when the skin is broken, there's a risk of germs getting into the body and causing an infection. Follow and track Wound Care News on BioPortfolio: Wound Car...


Corporate Database Quicklinks



Searches Linking to this Company Record